期刊文献+

食管鳞状细胞癌中Apaf-1基因启动子区甲基化状态及其与EZH2蛋白表达的关系 被引量:3

Promoter Methylation and Protein Expression of Apoptosis Protease Activating Factor-1 Gene in Esophageal Squamous Cell Carcinoma
下载PDF
导出
摘要 目的探讨食管鳞状细胞癌(ESCC)中凋亡蛋白酶活化因子-1(Apaf-1)启动子区的甲基化状态及其与EZH2蛋白表达之间的相关性。方法应用甲基化特异性PCR(MSP)方法检测128例食管鳞癌患者癌灶组织及相应癌旁组织的Apaf-1基因甲基化情况,应用免疫组织化学方法检测Apaf-1和EZH2的蛋白表达情况。结果 Apaf-1基因在食管鳞癌组织中的甲基化率为52.3%,显著高于癌旁正常组织的4.7%(P<0.01),不同肿瘤TNM分期患者的Apaf-1基因甲基化率差异有统计学意义(P<0.01)。食管鳞癌组织Apaf-1蛋白表达阳性率为41.4%,显著低于相应癌旁正常组织的94.5%(P<0.01)。食管鳞癌组织EZH2蛋白表达阳性率为72.7%,显著高于相应癌旁正常组织的12.5%(P<0.01),不同肿瘤TNM分期和组织分化程度患者的Apaf-1和EZH2蛋白阳性表达率差异有统计学意义(P<0.01)。食管鳞癌中Apaf-1基因甲基化与其蛋白阳性表达率呈负相关(r=-0.722),Apaf-1与EZH2的蛋白表达呈明显的负相关(r=-0.232)。结论 Apaf-1和EZH2可能共同参与了食管鳞癌的发生发展,Apaf-1基因启动子区的异常高甲基化可能是食管鳞癌中此基因失活的重要原因之一。 Objective To investigate the promoter methylation of apoptosis protease activating factor-1 (Apaf-1) and its association with the protein expression of enhancer of zeste homolog 2 (EZH2) in esophageal squamous cell carcinoma (ESCC). Methods The methylation-specific PCR (MSP) method was used to examine the methylation status of Apaf-1 in 128 ESCC patients, and immunohistochemistry method was used to detect the protein expression of Apaf-1 and EZH2 in tu- mors and corresponding normal tissues. Results The frequencies of Apaf-1 methylation in ESCC tumor tissues (52.3%, 67/ 128) were significantly higher than those in normal tissues (4.7%, 6/128) (P 〈 0.01), which was associated with TNM stage. The positive protein expression of Apaf-1 was significantly decreased in ESCC tumor tissues (41.4%, 53/128) compared with that of paired normal tissues (94.5%, 21/128) (P 〈 0.01). The positive protein expression of EZH2 was significantly increased in ESCC tumor tissues (72.7%, 93/128) than that of paired normal tissues (12.5%, 16/128) (P 〈 0.01). The protein expressions of Apaf-1 and EZH2 were associated with the TNM stage and pathological differentiation in ESCC patients (P 〈 0.01). The methylation status of Apaf-1 in ESCC was negatively correlated with the positive protein expression. The protein expressions of Apaf-1 and EZH2 were negatively correlated in ESCC. Conclusion Promoter hypermethylation of Apaf-1 and the higher protein expression of EZH2 may play important role in esophageal squamous cell carcinoma.
出处 《天津医药》 CAS 北大核心 2013年第3期193-196,J0001,共5页 Tianjin Medical Journal
基金 河北省医学科学研究重点课题计划项目(项目编号:20090465)
关键词 食管肿瘤 鳞状细胞 凋亡蛋白酶活化因子1 DNA甲基化 免疫组织化学 EZH2 esophageal neoplasms carcinoma, squamous cell apoptotic protease-activating factor 1 DNA methylation immunohistochemistry EZH2
  • 相关文献

参考文献14

  • 1Bratton SB,Salvesen GS. Regulation of the Apaf-1-caspase-9 apoptosome[J].Journal of Cell Science,2010,(Pt 19):3209-3214.
  • 2Reubold TF,Wohlgemuth S,Eschenburg S. A new model for the transition of APAF-1 from inactive monomer to caspase-activating apoptosome[J].Journal of Biological Chemistry,2009,(47):32717-32724.
  • 3Reubold TF,Eschenburg S. A molecular view on signal transduction by the apoptosome[J].Cellular Signalling,2012,(07):1420-1425.
  • 4Chang C J,Hung MC. The role of EZH2 in tumour progression[J].British Journal of Cancer,2012,(02):243-247.
  • 5Karanikolas BD,Figueiredo ML,Wu L. Comprehensive evaluation of the role of EZH2 in the growth,invasion,and aggression of a panel of prostate cancer cell lines[J].Prostate,2010,(06):675-688.
  • 6Gong Y,Huo L,Liu P. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome[J].Cancer,2011,(24):5476-5484.
  • 7Hinz S,Kempkensteffen C,Weikert S. EZH2 polycomb transcriptional repressor expression correlates with methylation of the APAF-1 gene in superficial transitional cell carcinoma of the bladder[J].Tumour Biology,2007,(03):151-157.
  • 8董稚明,郭炜,何明,杨植彬,邝钢,王士杰.贲门腺癌中RASSF1A基因的甲基化状态及表达[J].肿瘤防治研究,2009,36(7):566-570. 被引量:2
  • 9Bouras T,Southey MC,Venter DJ. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu[J].Cancer Research,2001,(03):903-907.
  • 10Hector S,Prehn JH. Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer:a review[J].Biochimica Et Biophysica Acta,2009,(02):117-129.

二级参考文献14

  • 1张立玮,温登瑰,王士杰,李英赛,于卫芳,王晓玲,王俊和,李素平,李永伟,王顺平,尔立绵,丛庆文,马彩芬.食管癌高发区贲门癌、胃癌流行强度分析及其对内镜筛查的启示[J].肿瘤防治研究,2005,32(12):792-795. 被引量:34
  • 2Zhu J, Yao X. Use of DNA methylation for cancer detection and molecular classification [J]. J Biochem Mol Biol, 2007, 40 (2):135-141.
  • 3Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 [J]. Nat Genet, 2000, 25 (3):315- 319.
  • 4Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands [J]. Proc Natl Acad Sci USA, 1996, 93 (18) : 9821- 9826.
  • 5Agathanggelou A, Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours [J]. Oncogene, 2001,20 (12) : 1509-1518.
  • 6Burbee DG, Forgacs E, Zochbauer-Muller S, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malig- nant phenotype suppression [J]. J Natl Cancer Inst, 2001,93 (9): 691-699.
  • 7Dammann R, Yang G, Pfeifer GP. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers [J].Cancer Res,2001,61 (7):3105-3109.
  • 8Lo KW, Kwong J, Hui AB, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma[J].Cancer Res,2001,61(10) :3877-3881.
  • 9Zhang YJ, Ahsan H, Chen Y, et al. High frequency of promoter hypermethylation of RASSF1A and p16 and its relation ship to aflatoxin B12DNA adduct levels in human hepatocellular carcinoma [J]. Mol Carcinog , 2002 , 35(2):85-92.
  • 10Byun DS, Lee MG, Chae KS,et al. Frequent epigenetic inactivation of RASSFI A by aberrant promoter hypermethylation in human gastric adenocarcinoma [J].Cancer Res,2001,61 (19) :7034-7038.

共引文献1

同被引文献53

  • 1赵敏,李智,于永春,段建敏,李晶华.膀胱癌组织中上皮细胞钙依粘连蛋白基因启动子区CpG岛甲基化状态的分析[J].检验医学,2005,20(1):55-58. 被引量:6
  • 2于月成,辛晓燕,汪海丹,李红梅,李奇灵,黄侃.上皮性卵巢癌CDH1基因启动子甲基化和蛋白表达的关系及意义[J].肿瘤,2006,26(4):363-366. 被引量:3
  • 3Reis-Filho JS, Tutt AN. Triple negative tumours: a critical review[J]. Histopathology, 2008, 52(1): 108-118.
  • 4Fiskus W, Buckley K, Rao R, et al. Panobinostat treatment depletes EZI-I2 and DNMT1 levels and enhances decitabine mediated de-repression ofJun B and loss of survival of human acute leukemia cells [J]. Cancer Biol Yher. 2009, 8 (10): 939-950.
  • 5Yoo KH, Hennighausen L. EZH2 methyltransferase and H3K27 methylation in breast cancer[J]. IntJ Biol Sci, 2012, 8(1): 59-65.
  • 6Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics[J]. Mutat Res, 2008, 647(1-2): 21-29.
  • 7Shen L, Cui J, Liang S, et al. Update of research on the role of EZH2 in cancer progression[J]. Onco Targets Ther, 2013, 6: 321-324.
  • 8van Kooten C, Lombardi G, Gelderman K_A_, et al. Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities [J]. Transplantation, 2011, 91 ( 1): 2-7.
  • 9Lin Y W, Chen I4 M, FangJ Y. Gene silencing by the polycomb group proteins and associations with cancer[J]. Cancer Invest, 2011, 29(3): 187-195.
  • 10Wang H, Albadine R, Magheli A, et al. Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder[J]. Urol Oncolj 2012j 30(4): 428-433.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部